The term “shadow docket” refers to the Supreme Court’s practice of issuing significant legal rulings through emergency orders and summary dispositions — without full briefing, oral argument, or signed majority opinions. The label was coined by law professor William Baude and has since migrated from academic discourse into mainstream political conversation, where it is sometimes framed as partisan grievance rather than institutional critique. The critique is legitimate regardless of which administration benefits from it.

The Trump administration’s executive order touching national parks management has revived a long-running argument about public land governance in the United States — an argument that is older than the current political alignment and will outlast it. The tension between conservation as federal stewardship and land use as economic opportunity has structured Interior Department policy debates since Theodore Roosevelt established the modern framework in the early twentieth century. The National Park System as currently constituted covers roughly 85 million acres across more than 400 designated sites.

Spirit Airlines filed for Chapter 11 bankruptcy in November 2024 and ceased operations shortly after, ending two decades of ultra-low-cost flying in the United States. The collapse was not sudden. It was the terminal stage of a business model that depended on razor-thin margins, a fee-heavy structure passengers increasingly resented, and a fleet expansion strategy that left the airline overextended when demand softened. The failed merger with Frontier in 2022, followed by the blocked acquisition by JetBlue in 2024, stripped Spirit of its two most viable exits.

Novo Nordisk is rolling out a tablet version of Ozempic (semaglutide) across the United States starting May 4, bringing a well-known injectable treatment into a pill format. It sounds simple—same drug, different delivery—but in reality, getting a peptide-based therapy into an oral form has been a long-standing scientific hurdle, so this is… kind of a big deal. For years, Ozempic has been associated with weekly injections, widely prescribed for adults with Type 2 diabetes not just to control blood sugar but also to reduce the risk of serious cardiovascular events like heart attacks and strokes.

Adobe will host a dedicated investor session at Adobe Summit, its flagship customer experience conference, on Tuesday, April 21, 2026, at 2:00 p.m. Pacific Time in Las Vegas, NV. The session is open to financial analysts and institutional investors and will feature remarks from Adobe’s executive leadership team. The agenda covers two core areas: company strategy and recent product innovations. Adobe Summit itself is the company’s largest annual gathering for digital experience practitioners, making the co-located investor session an opportunity to connect high-level financial messaging with live product and platform demonstrations happening across the conference floor.

Tempus AI, Inc. (NASDAQ: TEM) is moving deeper into the clinical workflow layer with the launch of an automated update service designed to keep cancer care aligned with the latest medical guidance in real time. The system introduces what the company describes as an “active follow-up” model, where patients remain continuously monitored after their initial genomic profiling rather than relying on a static report that can quickly lose relevance. At the center of this approach is an integrated workflow within Tempus’ physician platform, Hub.

Birch Coffee just opened its twelfth location in New York City, and the way they’re scaling is actually pretty straightforward—keep the vibe personal, but tighten everything behind the scenes. They’ve been leaning on Square to run most of the operational side, and it’s clearly working. The brand started back in 2009, founded by two bartenders who didn’t come from the coffee world at all. They kind of learned everything on the fly—sourcing beans, figuring out flavor profiles, building relationships with farmers in South America.

The question of what holds Europe together has no clean answer, which is precisely why it keeps being asked. Economic integration explains the structure. NATO explains the security architecture. But neither explains why people in Lisbon and Tallinn — sharing no language, no climate, no cuisine, no living memory of each other — can nonetheless recognize something common between them. European identity is not a legal category. It cannot be conferred by passport or treaty.

The economics of healthcare hiring have always had a strange flaw baked into them. Systems spend aggressively to attract talent, then act surprised when that same talent leaves once the incentives expire. What Clasp is doing—backed now by a $20 million Series B—isn’t just another HR-tech tweak. It’s an attempt to rewrite the incentive structure entirely, shifting the focus from recruitment spikes to long-term workforce stability. At the center of Clasp’s model is a concept borrowed from the military: early commitment.

Doctronic, an AI-native healthcare platform legally authorized to practice medicine in the United States, has announced a $40 million Series B funding round co-led by Abstract and Lightspeed Venture Partners, with participation from Union Square Ventures, Seven Stars, Mantis, and Tusk Ventures. The new financing brings total funding to more than $65 million, marking the company’s third round in less than 12 months and reinforcing investor confidence in its rapidly scaling model.